HRP20170380T1 - Životinje s humaniziranim il-5 - Google Patents

Životinje s humaniziranim il-5 Download PDF

Info

Publication number
HRP20170380T1
HRP20170380T1 HRP20170380TT HRP20170380T HRP20170380T1 HR P20170380 T1 HRP20170380 T1 HR P20170380T1 HR P20170380T T HRP20170380T T HR P20170380TT HR P20170380 T HRP20170380 T HR P20170380T HR P20170380 T1 HRP20170380 T1 HR P20170380T1
Authority
HR
Croatia
Prior art keywords
human
mouse
exons
humanized
protein
Prior art date
Application number
HRP20170380TT
Other languages
English (en)
Croatian (hr)
Inventor
Jose F. Rojas
Ka-Man Venus Lai
Andrew J. Murphy
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of HRP20170380T1 publication Critical patent/HRP20170380T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278Knock-in vertebrates, e.g. humanised vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5443IL-15
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/072Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/035Animal model for multifactorial diseases
    • A01K2267/0387Animal model for diseases of the immune system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8527Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HRP20170380TT 2013-10-15 2014-10-15 Životinje s humaniziranim il-5 HRP20170380T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361891013P 2013-10-15 2013-10-15
EP14790452.8A EP2908626B1 (en) 2013-10-15 2014-10-15 Humanized il-15 animals
PCT/US2014/060568 WO2015057758A1 (en) 2013-10-15 2014-10-15 Humanized il-15 animals

Publications (1)

Publication Number Publication Date
HRP20170380T1 true HRP20170380T1 (hr) 2017-05-19

Family

ID=51830649

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20170380TT HRP20170380T1 (hr) 2013-10-15 2014-10-15 Životinje s humaniziranim il-5
HRP20190542TT HRP20190542T1 (hr) 2013-10-15 2019-03-20 Životinje s humaniziranim il-15

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20190542TT HRP20190542T1 (hr) 2013-10-15 2019-03-20 Životinje s humaniziranim il-15

Country Status (27)

Country Link
US (5) US9155290B2 (enExample)
EP (3) EP3461331A1 (enExample)
JP (3) JP6492095B2 (enExample)
KR (1) KR102376041B1 (enExample)
CN (2) CN109090037B (enExample)
AU (2) AU2014337526B2 (enExample)
BR (1) BR112016008175A2 (enExample)
CA (1) CA2926090C (enExample)
CY (2) CY1118675T1 (enExample)
DK (2) DK2908626T3 (enExample)
ES (2) ES2715949T3 (enExample)
HR (2) HRP20170380T1 (enExample)
HU (2) HUE043969T2 (enExample)
IL (2) IL244525B (enExample)
LT (2) LT2908626T (enExample)
MX (1) MX2016004781A (enExample)
NZ (1) NZ718655A (enExample)
PL (2) PL3138397T3 (enExample)
PT (2) PT2908626T (enExample)
RS (2) RS58465B1 (enExample)
RU (1) RU2674910C2 (enExample)
SG (2) SG10201607768YA (enExample)
SI (2) SI3138397T1 (enExample)
SM (3) SMT201900177T1 (enExample)
TR (1) TR201904342T4 (enExample)
WO (1) WO2015057758A1 (enExample)
ZA (1) ZA201601676B (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3040377C (en) 2009-10-06 2025-12-30 Yale University Genetically modified mice and engraftment comprising the knock-in of a human thrombopoietin (tpo) gene
ES3040596T3 (en) 2011-02-15 2025-11-03 Regeneron Pharma Humanized m-csf mice and uses thereof
KR102287541B1 (ko) 2012-09-07 2021-08-10 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
EP4389764B1 (en) 2012-11-05 2026-03-18 Regeneron Pharmaceuticals, Inc. Genetically modified rodents and methods of use thereof
SMT201900177T1 (it) 2013-10-15 2019-05-10 Regeneron Pharma Animali con il-15 umanizzata
SG10201811701YA (en) 2013-11-19 2019-01-30 Regeneron Pharma Non-human animals having a humanized a proliferation-inducing ligand gene
JP6598798B2 (ja) 2014-05-05 2019-10-30 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化c5およびc3動物
NO2785538T3 (enExample) 2014-05-07 2018-08-04
KR20250096864A (ko) 2014-05-19 2025-06-27 리제너론 파마슈티칼스 인코포레이티드 인간 epo를 발현하는 유전자 변형된 비-인간 동물
KR102617691B1 (ko) 2014-12-05 2023-12-27 리제너론 파마슈티칼스 인코포레이티드 인간화 분화 클러스터 47 유전자를 가진 비인간 동물
JP6752221B2 (ja) 2015-04-13 2020-09-09 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化sirpa−il15ノックインマウス及びその使用方法
CN108779159B (zh) 2016-02-04 2022-12-30 瑞泽恩制药公司 具有经改造的angptl8基因的非人动物
JP6980674B2 (ja) 2016-02-29 2021-12-15 リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. ヒト化tmprss遺伝子を有する齧歯類
DK3476865T5 (da) 2016-06-28 2024-09-09 Biocytogen Pharmaceuticals Beijing Co Ltd Fremgangsmåde til konstruktion af pd-1-gen-modificeret humaniseret dyremodel og anvendelse deraf
CN107815467B (zh) 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
WO2018041121A1 (en) 2016-08-31 2018-03-08 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric ctla-4
WO2018041119A1 (en) 2016-08-31 2018-03-08 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric ox40
DK3507373T5 (da) 2016-08-31 2024-09-02 Biocytogen Pharmaceuticals Beijing Co Ltd Genetisk modificeret ikke-menneskeligt dyr med human eller kimær pd-l1
WO2018041120A1 (en) 2016-08-31 2018-03-08 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric tigit
CN107815468B (zh) 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
CN108070613B (zh) 2016-11-11 2020-03-13 百奥赛图江苏基因生物技术有限公司 人源化基因改造动物模型的制备方法及应用
WO2018086594A1 (en) 2016-11-11 2018-05-17 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric tim-3
EP3547831A1 (en) 2016-11-30 2019-10-09 The Jackson Laboratory Humanized mouse model with improved human innate immune cell development
CN108239659B (zh) 2016-12-23 2020-03-03 百奥赛图江苏基因生物技术有限公司 人源化基因改造动物模型的制备方法及应用
CN108424928B (zh) 2016-12-30 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
CN108467873B (zh) 2017-03-17 2020-03-13 百奥赛图江苏基因生物技术有限公司 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用
WO2018177441A1 (en) 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (zh) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Cd47基因人源化改造动物模型的制备方法及应用
CN109136275B (zh) 2017-06-19 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化gitr基因改造动物模型的制备方法及应用
CN109136261B (zh) 2017-06-19 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化cd28基因改造动物模型的制备方法及应用
CN109136274B (zh) 2017-06-19 2021-04-23 百奥赛图江苏基因生物技术有限公司 人源化cd40基因改造动物模型的制备方法及应用
WO2019032836A1 (en) * 2017-08-09 2019-02-14 The Jackson Laboratory IMMUNODEFICIENT MOUSE EXPRESSING THE HUMAN INTERLEUKINE 15
ES2962277T3 (es) 2017-09-29 2024-03-18 Regeneron Pharma Roedores que comprenden un locus Ttr humanizado y métodos de uso
WO2019072241A1 (en) 2017-10-13 2019-04-18 Beijing Biocytogen Co., Ltd NON-HUMAN ANIMAL GENETICALLY MODIFIED WITH PD-1 HUMAN OR CHIMERIC
CN109913493B (zh) 2017-12-12 2021-03-16 百奥赛图江苏基因生物技术有限公司 人源化cd3基因改造动物模型的制备方法及应用
HRP20240999T1 (hr) 2018-07-16 2024-10-25 Regeneron Pharmaceuticals, Inc. Glodavački modeli bolesti ditra i njihova upotreba
WO2020074005A1 (en) 2018-10-12 2020-04-16 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric genes
WO2020125763A1 (en) 2018-12-20 2020-06-25 Biocytogen Jiangsu Co., Ltd. Genetically modified non-human animal with human or chimeric lag3
WO2020135518A1 (en) * 2018-12-25 2020-07-02 Biocytogen Jiangsu Co., Ltd. Genetically modified non-human animal with human or chimeric il15
CN114164177A (zh) * 2019-01-17 2022-03-11 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
WO2020206139A1 (en) 2019-04-04 2020-10-08 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized coagulation factor 12 locus
EP3801011A1 (en) 2019-06-04 2021-04-14 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
AU2020289581B2 (en) 2019-06-07 2024-11-21 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
CN114786479B (zh) * 2019-12-25 2023-12-15 江苏集萃药康生物科技股份有限公司 一种il-15人源化小鼠模型及其用途
US12250931B2 (en) * 2020-01-28 2025-03-18 Regeneron Pharmaceuticals, Inc. Genetically modified mouse with a humanized PNPLA3 gene and methods of use
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术(上海)有限公司 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法
CN112481303B (zh) * 2021-02-09 2021-05-25 百奥赛图(北京)医药科技股份有限公司 Il15ra基因人源化非人动物及其构建方法和应用
WO2025212991A1 (en) 2024-04-05 2025-10-09 Regeneron Pharmaceuticals, Inc. Rodent models of disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001058914A2 (en) * 2000-02-08 2001-08-16 Genaissance Pharmaceuticals, Inc. Haplotypes of the interleukin 15 gene
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
EP3263581B2 (en) * 2005-05-17 2025-07-09 University of Connecticut Compositions and methods for immunomodulation in an organism
PT3456190T (pt) * 2008-06-27 2022-02-15 Merus Nv Animal murino transgénico produtor de anticorpo
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
CA3040377C (en) 2009-10-06 2025-12-30 Yale University Genetically modified mice and engraftment comprising the knock-in of a human thrombopoietin (tpo) gene
MY156743A (en) * 2009-12-21 2016-03-31 Regeneron Pharma Humanized fc?r mice
ES3040596T3 (en) 2011-02-15 2025-11-03 Regeneron Pharma Humanized m-csf mice and uses thereof
RS56330B1 (sr) * 2011-10-28 2017-12-29 Regeneron Pharma Genetski modifikovani miševi sa ekspresijom himernih molekula klase ii glavnog kompleksa histokompatibilnosti (mhc)
MY186903A (en) 2011-10-28 2021-08-26 Regeneron Pharma Humanized il-6 and il-6 receptor
RS56656B1 (sr) 2011-10-28 2018-03-30 Regeneron Pharma Miševi sa genetski modifikovanim glavnim kompleksom gena tkivne podudarnosti
US9043996B2 (en) * 2011-10-28 2015-06-02 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex animals
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
KR102287541B1 (ko) 2012-09-07 2021-08-10 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
EP4389764B1 (en) 2012-11-05 2026-03-18 Regeneron Pharmaceuticals, Inc. Genetically modified rodents and methods of use thereof
CN110192541B (zh) 2013-02-22 2022-02-18 瑞泽恩制药公司 表达人源化主要组织相容性复合物的小鼠
DK3175706T3 (en) 2013-09-23 2019-03-04 Regeneron Pharma Non-human animals with a humanized signal regulatory protein gene
SMT201900177T1 (it) 2013-10-15 2019-05-10 Regeneron Pharma Animali con il-15 umanizzata

Also Published As

Publication number Publication date
NZ718655A (en) 2022-08-26
JP6600061B2 (ja) 2019-10-30
PL3138397T3 (pl) 2019-06-28
US20180116192A1 (en) 2018-05-03
IL244525A0 (en) 2016-04-21
HUE033272T2 (en) 2017-11-28
JP2016533192A (ja) 2016-10-27
RU2674910C2 (ru) 2018-12-13
KR102376041B1 (ko) 2022-03-18
WO2015057758A1 (en) 2015-04-23
AU2014337526A1 (en) 2016-04-28
US20150366175A1 (en) 2015-12-24
SG10201607768YA (en) 2016-11-29
IL244525B (en) 2019-10-31
LT3138397T (lt) 2019-04-10
PT3138397T (pt) 2019-03-26
EP2908626A1 (en) 2015-08-26
RU2016116847A3 (enExample) 2018-06-07
AU2020286186B2 (en) 2024-05-23
JP2019022518A (ja) 2019-02-14
EP3138397B1 (en) 2018-12-26
HRP20190542T1 (hr) 2019-07-26
SMT201700024B (it) 2017-03-08
US20150106961A1 (en) 2015-04-16
LT2908626T (lt) 2017-01-25
US12369570B2 (en) 2025-07-29
US11503813B2 (en) 2022-11-22
CN109090037B (zh) 2021-05-28
EP3138397A1 (en) 2017-03-08
AU2014337526B2 (en) 2020-09-10
CN105744829A (zh) 2016-07-06
MX2016004781A (es) 2016-07-26
HUE043969T2 (hu) 2019-09-30
CN105744829B (zh) 2018-08-07
ZA201601676B (en) 2019-12-18
ES2613379T3 (es) 2017-05-24
CY1118675T1 (el) 2018-03-07
RU2016116847A (ru) 2017-11-21
EP2908626B1 (en) 2016-12-07
RS58465B1 (sr) 2019-04-30
SMT201900177T1 (it) 2019-05-10
SI3138397T1 (sl) 2019-04-30
HK1210659A1 (en) 2016-05-06
IL269907B (en) 2020-09-30
SG11201601828XA (en) 2016-04-28
AU2020286186A1 (en) 2021-01-07
DK3138397T3 (en) 2019-04-15
PT2908626T (pt) 2017-01-09
ES2715949T3 (es) 2019-06-07
CN109090037A (zh) 2018-12-28
RS55472B1 (sr) 2017-04-28
BR112016008175A2 (pt) 2017-10-03
PL2908626T3 (pl) 2017-05-31
US20230189772A1 (en) 2023-06-22
CY1121405T1 (el) 2020-05-29
JP2019216750A (ja) 2019-12-26
CA2926090A1 (en) 2015-04-23
US20200178508A1 (en) 2020-06-11
US10561125B2 (en) 2020-02-18
KR20160068774A (ko) 2016-06-15
TR201904342T4 (tr) 2019-05-21
SI2908626T1 (sl) 2017-02-28
SMT201700024T1 (it) 2017-03-08
CA2926090C (en) 2022-07-05
EP3461331A1 (en) 2019-04-03
DK2908626T3 (en) 2017-03-20
JP6492095B2 (ja) 2019-03-27
US9155290B2 (en) 2015-10-13

Similar Documents

Publication Publication Date Title
HRP20170380T1 (hr) Životinje s humaniziranim il-5
JP2019022518A5 (enExample)
WO2015077072A4 (en) Non-human animals having a humanized a proliferation-inducing ligand gene
RU2014148107A (ru) Грызуны с гуманизированным il-7
HRP20200899T1 (hr) Neljudske životinje koje imaju humanizirane fc-gamma receptore
RU2016123708A (ru) Отличные от человека животные, содержащие гуманизированный ген фактора активации в-клеток
FI4233537T3 (fi) Humanisoituja m-csf-hiiriä ja niiden käyttötapoja
RU2017129763A (ru) Гуманизированные il-6 и рецептор il-6
JP2010516235A5 (enExample)
JP2012065678A5 (enExample)
PH12015500213A1 (en) Production of fmdv-resistant livestock by allele substitution
HRP20180242T1 (hr) Životinje s humaniziranim il-4 i il-4r alfa
IL307969A (en) Genetically modified non-human animals and methods of their use
NZ712508A (en) Non-human animals expressing ph-sensitive immunoglobulin sequences
JP2017514496A5 (enExample)
JP2016523561A5 (enExample)
MX2019001598A (es) Reduccion de nitrosamina especifica de tabaco en plantas.
MX2016014635A (es) Reduccion de la conversion de nicotina a nornicotina en plantas.
AR102888A1 (es) Animales no humanos que tienen un gen humanizado de agrupamiento de diferenciación 47
HRP20192311T4 (hr) Adam6 miševi
FI3823443T3 (fi) Ditra-taudin jyrsijämallit ja niiden käyttö
WO2013092743A3 (en) Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides
RU2016105639A (ru) Гены, обеспечивающие устойчивость подсолнечника к ложной мучнистой росе
EP4057807A4 (en) GENETICALLY MODIFIED NON-HUMAN ANIMAL CONTAINING HUMAN OR CHIMERIC GENES
EA201490958A1 (ru) Засухоустойчивые растения, полученные путем модификации генного локуса stgx, ответственного за фенотип оставаться зеленым